Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)

Abroad (travel likely)RecruitingPHASE1

Conditions

FSHD - Facioscapulohumeral Muscular Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stanford Neuroscience Health Center, Palo Alto, California, United States
Contact: Study coordinator (Neuromuscular Clinical Research Coordinator) · (neuromuscularresearch@stanford.edu · 650-460-4596
Contact: Principal Investigator (John W Day, MD, PhD)

Study leads

John W Day, MD, PhD
Principal Investigator
Stanford University, School of Medicine, Neuromuscular Research Division

View source on ClinicalTrials.gov